Simultaneous determination of lesinurad and febuxostat in commercial fixed-dose combinations using a greener normal-phase HPTLC method
So far, no documented method for simultaneously analyzing lesinurad (LND) and febuxostat (FBX) has been reported for either traditional high-performance thin-layer chromatography (HPTLC) or a green HPTLC technique. In order to determine LND and FBX simultaneously in commercially available fixed-dose...
Main Authors: | , , , , , , , |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2024-04-01
|
Series: | Green Processing and Synthesis |
Subjects: | |
Online Access: | https://doi.org/10.1515/gps-2023-0264 |